PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
23.24%
Positive revenue growth while FSLR is negative. John Neff might see a notable competitive edge here.
-253.92%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-554.55%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-215.67%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-390.49%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-296.15%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-296.15%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-38.35%
Share reduction while FSLR is at 0.01%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-38.35%
Reduced diluted shares while FSLR is at 0.03%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-697.99%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-612.15%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-98.55%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-97.80%
Negative 5Y CAGR while FSLR stands at 59.83%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-96.08%
Negative 3Y CAGR while FSLR stands at 51.09%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-15.34%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-12.63%
Negative 5Y OCF/share CAGR while FSLR is at 83.34%. Joel Greenblatt would question the firm’s operational model or cost structure.
-107.79%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-523.77%
Negative 10Y net income/share CAGR while FSLR is at 231.27%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-882.15%
Negative 5Y net income/share CAGR while FSLR is 906.23%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-111.99%
Negative 3Y CAGR while FSLR is 587.62%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-117.92%
Negative equity/share CAGR over 10 years while FSLR stands at 48.28%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-61.98%
Negative 5Y equity/share growth while FSLR is at 44.26%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-189.42%
Negative 3Y equity/share growth while FSLR is at 29.36%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-34.77%
Firm’s AR is declining while FSLR shows 14.45%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-70.14%
Inventory is declining while FSLR stands at 46.21%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
223.24%
Asset growth above 1.5x FSLR's 3.83%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-151.68%
We have a declining book value while FSLR shows 4.66%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
191.33%
Debt growth far above FSLR's 11.61%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
211.71%
SG&A growth well above FSLR's 8.61%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.